Double de novo mutations of ELANE (ELA2) in a patient with severe congenital neutropenia requiring high-dose G-CSF therapy. [electronic resource]
Producer: 20100330Description: 587-90 p. digitalISSN:- 1365-2141
No physical items for this record
Publication Type: Case Reports; Letter; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.